- The Foundation For Peripheral Neuropathy - https://www.foundationforpn.org -

Phase 3 Data Show NUCYNTA® ER Extended-Release Tablets Provide Pain Relief Management

Janssen Pharmaceuticals, Inc. presented results at the 31st Annual Scientific Meeting of the American Pain Society suggesting these extended-release tablets were significantly more effective than placebo in providing pain management among adults with chronic moderate to severe, painful diabetic peripheral neuropathy. “Painful DPN is a common and burdensome complication of diabetes, and controlling pain in people with DPN can be challenging,” said Aaron Vinik, MD, PhD, Director of Research and Neuroendocrine Unit at Strelitz Diabetes Center for Endocrine and Metabolic Disorders at Eastern Virginia Medical School.  READ MORE [1]

Source: PR Newswire